NOS2 and adenocarcinoma: Our data therefore indicate that iNOS, in the C26‐adenocarcinoma model, affects acylcarnitine‐mediated energy production in the mitochondria by interfering with the relationship between acylcarnitine metabolism and the TCA cycle as well as deregulating critical enzymes in β‐oxidation.